Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The study will assess the performance of the combined system, i.e., the use of the EsoGuard assay on cells collected using the EsoCheck 510(k) cleared device, to detect Barrett\'s Esophagus, with and without dysplasia, and/or Esophageal Adenocarcinoma, in individuals deemed to be at high risk for these conditions (i.e., screening) per ACG guidelines.
Epistemonikos ID: 0d8955926f3d9e49213bdbec1fb2c61b1920f36b
First added on: May 07, 2024